You have 9 free searches left this month | for more free features.

Carboxylesterase 1 (CES1)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Impact of CES1 Genotype on Remimazolam

Not yet recruiting
  • American Society of Anesthesiologists (ASA) Class 1-2
  • +3 more
  • Remimazolam besylate
  • (no location specified)
Apr 24, 2023

ADHD, ADHD Trial in United States (Methylphenidate)

Recruiting
  • ADHD
  • Attention Deficit Hyperactivity Disorder
  • Gainesville, Florida
  • +3 more
Apr 5, 2022

Myocardial Infarction, Thrombosis, Platelet Dysfunction Trial in Lancaster (Clopidogrel, Ticagrelor)

Recruiting
  • Myocardial Infarction
  • +2 more
  • Lancaster, Pennsylvania
    Amish Research Clinic
Jan 24, 2022

Heart Diseases, Coronary Disease, Coronary Artery Disease Trial in Lancaster (Clopidogrel, Aspirin)

Enrolling by invitation
  • Heart Diseases
  • +9 more
  • Lancaster, Pennsylvania
    Amish Research Clinic
Jan 24, 2022

Drug Interaction Trial in Gainesville (di-Methylphenidate plus Cannabidiol, di-Methylphenidate plus Cannabidiol Placebo

Completed
  • Drug Interaction
  • di-Methylphenidate plus Cannabidiol
  • di-Methylphenidate plus Cannabidiol Placebo solution
  • Gainesville, Florida
    University of Florida
Feb 17, 2022

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Active, not recruiting
  • Recurrent Anaplastic Astrocytoma
  • +6 more
  • Carboxylesterase-expressing Allogeneic Neural Stem Cells
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

NRG - Part 1: Validation of Methods for Estimating Resting

Not yet recruiting
  • Sedentary
  • +2 more
    • Medellín, Antioquia, Colombia
    • +1 more
    Apr 15, 2023

    Coronary Artery Disease Trial in Japan (Cilostazol eluting stent system (CES-1))

    Active, not recruiting
    • Coronary Artery Disease
    • Cilostazol eluting stent system (CES-1)
    • Isehara, Kanagawa, Japan
    • +5 more
    Mar 28, 2022

    Neurological Complication, in Particular TNS or CES Trial in Malle (2-chloroprocaine HCl, 1%)

    Completed
    • Neurological Complication, in Particular TNS or CES
    • 2-chloroprocaine hydrochloride, 1%
    • Malle, Belgium
      Department of Anesthesiology and Critical Care Medicine-Hospital
    Jun 8, 2021

    Treatment Outcomes in Freeman-Sheldon Syndrome

    Terminated
    • Freeman-Sheldon Syndrome
    • +15 more
    • PTSD Checklist-Civilian (PCL-C)
    • +6 more
    • Buckhannon, West Virginia
      Freeman-Sheldon Research Group, Inc. Headquarters
    Jun 15, 2022

    CES1 Genotype and Methylphenidate Response in ADHD - INDICES

    Completed
    • ADHD
    • (no location specified)
    Apr 27, 2020

    Metabolic Disease Trial in Bangkok (Oseltamivir)

    Completed
    • Metabolic Disease
    • Bangkok, Thailand
      The Faculty of Tropical medicine,Mahidol University
    Jun 25, 2018

    Healthy Volunteers Trial in Ann Arbor (Enalapril)

    Suspended
    • Healthy Volunteers
    • Ann Arbor, Michigan
      University of Michigan
    Feb 2, 2022

    Pancreatic Cancer Trial in Goyang-si

    Active, not recruiting
    • Pancreatic Cancer
      • Goyang-si, Gyeonggi-do, Korea, Republic of
        NATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu,
      Sep 27, 2022

      Teeth, Impacted Trial in Medellín (Bupivacaine-epinephrine, Saline Solution)

      Completed
      • Teeth, Impacted
      • Medellín, Colombia
        CES University
      May 14, 2020

      Adolescent Depression Trial in Chapel Hill (Healthy Minds Program)

      Recruiting
      • Adolescent Depression
      • Healthy Minds Program
      • Chapel Hill, North Carolina
        Carolina Crossing B, Suite 1
      Oct 2, 2023

      Crohn's Disease Trial in Worldwide (Guselkumab Dose 1, Guselkumab Dose 2, Guselkumab Dose 3)

      Active, not recruiting
      • Crohn's Disease
      • Guselkumab Dose 1
      • +7 more
      • Dothan, Alabama
      • +574 more
      Jan 31, 2023

      Depression and Glycemic Control in People With Type 1 Diabetes

      Recruiting
      • Type 1 Diabetes
      • Depression Questionnaires
      • Roma, Italy
        Università Cattolica del Sacro Cuore
      Jul 10, 2023

      Diabetes, Type 1 Trial in Augusta (Antioxidant Cocktail, Resveratrol, Placebo)

      Recruiting
      • Diabetes Mellitus, Type 1
      • Antioxidant Cocktail
      • +2 more
      • Augusta, Georgia
      • +1 more
      Jul 18, 2022

      Mindfulness Based Dementia Care Study

      Enrolling by invitation
      • Caregiver Burnout
        • Saint Paul, Minnesota
          HealthPartners Neuroscience Center
        Feb 1, 2023

        Anxiety Depression, Burnout Trial in Palo Alto (Mindfulness session)

        Completed
        • Anxiety Depression
        • Burnout
        • Mindfulness session
        • Palo Alto, California
          Stanford Health Care
        Dec 8, 2022

        Dysarthria as Late Effect of Stroke Trial (Smartphone-based speech therapy, Home-based speech therapy)

        Not yet recruiting
        • Dysarthria as Late Effect of Stroke
        • Smartphone-based speech therapy
        • Home-based speech therapy
        • (no location specified)
        May 17, 2023

        ImplementingAdolescent and Young Adult mHealth Vaping Cessation

        Recruiting
        • Vaping
        • Vaping Cessation
          • Memphis, Tennessee
            St. Jude Children's Research Hospital
          Jul 28, 2023

          Generalized Anxiety Disorder Trial in Chapel Hill (At-Home Stimulation)

          Not yet recruiting
          • Generalized Anxiety Disorder
          • At-Home Stimulation
          • Chapel Hill, North Carolina
            Carolina Center for Neurostimulation
          Nov 3, 2023

          Dysarthria as Late Effect of Stroke Trial (Smartphone-based speech therapy, Traditional speech therapy)

          Not yet recruiting
          • Dysarthria as Late Effect of Stroke
          • Smartphone-based speech therapy
          • Traditional speech therapy
          • (no location specified)
          May 17, 2023